I agree that this site is using cookies. You can find further informations here.
X
Nijhof, Inger S.
164  results:
Search for persons X
?
1

Assessing frailty in myeloma: The pursuit of simplicity may..:

Groen, Kazimierz ; Smits, Febe ; Nasserinejad, Kazem...
HemaSphere.  8 (2024)  7 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

P877: IXAZOMIB DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN IN..:

Groen, Kaz ; Stege, Claudia ; Nasserinejad, Kazem...
HemaSphere.  7 (2023)  S3 - p. e25266f8 , 2023
Link: https://doi.org/10.1097/..
 
?
3

P1536: SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC ..:

Haggenburg, Sabine ; Reuvekamp, Tom ; Hofsink, Quincy...
HemaSphere.  7 (2023)  S3 - p. e2387009 , 2023
Link: https://doi.org/10.1097/..
 
?
4

The Dutch CAR-T Tumorboard Experience: Population-Based Rea..:

Spanjaart, Anne M. ; Pennings, Elise R. A. ; Mutsaers, Pim G. N. J....
Cancers.  15 (2023)  17 - p. 4334 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Fourth mRNA COVID-19 vaccination in immunocompromised patie..:

Hofsink, Quincy ; Haggenburg, Sabine ; Lissenberg-Witte, Birgit I....
eClinicalMedicine.  61 (2023)  - p. 102040 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Ixazomib, daratumumab and low-dose dexamethasone in interme..:

Groen, Kaz ; Stege, Claudia A.M. ; Nasserinejad, Kazem...
eClinicalMedicine.  63 (2023)  - p. 102167 , 2023
Link: https://doi.org/10.1016/..
 
?
7

SARS-CoV-2 vaccine-induced humoral and cellular immunity in..:

Haggenburg, Sabine ; Hofsink, Quincy ; Rutten, Caroline E....
Seminars in Hematology.  59 (2022)  4 - p. 192-197 , 2022
Link: https://doi.org/10.1053/..
 
?
8

Hyperimmune Globulin for Severely Immunocompromised Patient..:

Huygens, Sammy ; Hofsink, Quincy ; Nijhof, Inger S...
The Journal of Infectious Diseases.  227 (2022)  2 - p. 206-210 , 2022
Link: https://doi.org/10.1093/..
 
?
9

Efficacy and safety of daratumumab combined with all-transr..:

Frerichs, Kristine A. ; Minnema, Monique C. ; Levin, Mark-David...
Blood Advances.  5 (2021)  23 - p. 5128-5139 , 2021
Link: https://doi.org/10.1182/..
 
?
10

Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell M..:

van der Horst, Hilma J. ; Oostindie, Simone C. ; Cillessen, Saskia. A. G. M....
HemaSphere.  5 (2021)  1 - p. e504 , 2021
Link: https://doi.org/10.1097/..
 
?
11

Improving the identification of frail elderly newly diagnos..:

Stege, Claudia A. M. ; Nasserinejad, Kazem ; Klein, Saskia K....
Leukemia.  35 (2021)  9 - p. 2715-2719 , 2021
Link: https://doi.org/10.1038/..
 
?
12

Potent preclinical activity of HexaBody-DR5/DR5 in relapsed..:

van der Horst, Hilma J. ; Gelderloos, Anne T. ; Chamuleau, Martine E. D....
Blood Advances.  5 (2021)  8 - p. 2165-2172 , 2021
Link: https://doi.org/10.1182/..
 
?
13

Resistance Mechanisms towards CD38−Directed Antibody Therap..:

Franssen, Laurens E. ; Stege, Claudia A. M. ; Zweegman, Sonja..
Journal of Clinical Medicine.  9 (2020)  4 - p. 1195 , 2020
Link: https://doi.org/10.3390/..
 
?
14

Cerebrospinal Fluid Penetrance of Daratumumab in Leptomenin..:

Zajec, Marina ; Frerichs, Kristine A. ; van Duijn, Martijn M....
HemaSphere.  4 (2020)  4 - p. , 2020
Link: https://doi.org/10.1097/..
 
?
15

Fc-Engineered Antibodies with Enhanced Fc-Effector Function..:

van der Horst, Hilma J. ; Nijhof, Inger S. ; Mutis, Tuna.
Cancers.  12 (2020)  10 - p. 3041 , 2020
Link: https://doi.org/10.3390/..
 
1-15